China National Accord Medicines Corp Ltd
SZSE:000028
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
China National Accord Medicines Corp Ltd
Cash from Investing Activities
China National Accord Medicines Corp Ltd
Cash from Investing Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
China National Accord Medicines Corp Ltd
SZSE:000028
|
Cash from Investing Activities
-¥102.9m
|
CAGR 3-Years
33%
|
CAGR 5-Years
48%
|
CAGR 10-Years
15%
|
|
|
Sinopharm Group Co Ltd
HKEX:1099
|
Cash from Investing Activities
-¥3.2B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-7%
|
|
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Cash from Investing Activities
-¥4B
|
CAGR 3-Years
32%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-8%
|
|
|
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Cash from Investing Activities
¥908.4m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
C
|
China National Medicines Corp Ltd
SSE:600511
|
Cash from Investing Activities
-¥17.4m
|
CAGR 3-Years
51%
|
CAGR 5-Years
21%
|
CAGR 10-Years
11%
|
|
|
Huadong Medicine Co Ltd
SZSE:000963
|
Cash from Investing Activities
¥254.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
China National Accord Medicines Corp Ltd
Glance View
China National Accord Medicines Corp Ltd, nestled within the bustling healthcare landscape of China, operates at the heart of the pharmaceutical distribution and retail sectors. Established with the goal of ensuring that essential medicines and healthcare services are accessible to the vast Chinese population, the company has built an extensive distribution network. This network efficiently links manufacturers with hospitals, clinics, and pharmacies, making certain that a myriad of pharmaceutical products reach their intended destinations. By leveraging a combination of logistical prowess and vast geographical coverage, the company adeptly navigates the complexities of supply chain management, underscoring its role as a critical player in China's healthcare infrastructure. Beyond distribution, China National Accord Medicines also capitalizes on the booming retail pharmaceuticals market through its chain of pharmacies. These retail outlets serve as direct points of sale to consumers, offering both prescription and over-the-counter medications, alongside health consultation services. This dual focus on both wholesale distribution and retail outlets enables the company to capture value across the supply chain, from manufacturer to end-user. The strategic alignment of its operations streamlines efficiency and generates revenue, sustaining its growth amid a fiercely competitive and rapidly evolving market. Through this integrated approach, the company solidifies its position as a crucial conduit in the delivery of healthcare solutions across China.
See Also
What is China National Accord Medicines Corp Ltd's Cash from Investing Activities?
Cash from Investing Activities
-102.9m
CNY
Based on the financial report for Dec 31, 2025, China National Accord Medicines Corp Ltd's Cash from Investing Activities amounts to -102.9m CNY.
What is China National Accord Medicines Corp Ltd's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
15%
Over the last year, the Cash from Investing Activities growth was 32%. The average annual Cash from Investing Activities growth rates for China National Accord Medicines Corp Ltd have been 33% over the past three years , 48% over the past five years , and 15% over the past ten years .